Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 3,636 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q2
TARPLIN, DOWNS & YOUNG, LLC for SAREPTA THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $90,000.00 income
Budget/Appropriations, Health Issues, Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for OTSUKA AMERICA PHARMACEUTICAL, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · $50,000.00 income
Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for MERCK & CO., INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $50,000.00 income
Medicare/Medicaid
View →
Q2
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for FORREST GENERAL HOSPITAL
2nd Quarter (Apr 1 - June 30) 2026 · Mississippi · House · Senate · $20,000.00 income
Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for MEDTRONIC, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $40,000.00 income
Medicare/Medicaid
View →
Q2
THE SMITH-FREE GROUP, LLC for AMERICAN HOSPITAL ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
W STRATEGIES, LLC for IPSEN BIOPHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · $20,000.00 income
Medicare/Medicaid
View →
Q2
MASSACHUSETTS MEDICAL SOCIETY for MASSACHUSETTS MEDICAL SOCIETY
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid, Insurance, Tobacco
View →
Q2
W STRATEGIES, LLC for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · $60,000.00 income
Medicare/Medicaid
View →
Q2
CARMEN GROUP INCORPORATED for PEDIATRIX MEDICAL GROUP INC
2nd Quarter (Apr 1 - June 30) 2026 · Florida · Senate · $90,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
W STRATEGIES, LLC for GLAXOSMITHKLINE
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $40,000.00 income
Medicare/Medicaid
View →
Q2
TARPLIN, DOWNS & YOUNG, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Budget/Appropriations, Medicare/Medicaid, Health Issues
View →
Q2
W STRATEGIES, LLC for GILEAD SCIENCES, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · $60,000.00 income
Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for EXELIXIS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · $60,000.00 income
Medicare/Medicaid
View →
Q2
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for CHARTSPAN
2nd Quarter (Apr 1 - June 30) 2026 · South Carolina · House · Senate
Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for DELFI DIAGNOSTICS
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · $30,000.00 income
Medicare/Medicaid
View →
Q2
MILLER STRATEGIES, LLC for RTW INVESTMENTS, LP
2nd Quarter (Apr 1 - June 30) 2026 · New York · $150,000.00 income
Pharmacy, Medicare/Medicaid, Transportation, Medical/Disease Research/Clinical Labs
View →
Q2
W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $40,000.00 income
Medicare/Medicaid
View →
Q2
NOVO NORDISK INC. for NOVO NORDISK INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark
View →
Q2
W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for ABBVIE INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
TARPLIN, DOWNS & YOUNG, LLC for CALIFORNIA PROTONS CANCER THERAPY CENTER
2nd Quarter (Apr 1 - June 30) 2026 · California · $80,000.00 income
Medicare/Medicaid
View →
Q2
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate
Budget/Appropriations, Pharmacy, Medicare/Medicaid
View →
Q2
AVENUE SOLUTIONS for VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION for AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Budget/Appropriations, Health Issues, Taxation/Internal Revenue Code
View →
Previous Page 23 of 146 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem